| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1370603
[patent_doc_number] => 06562618
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Monoclonal antibody against connective tissue growth factor and medicinal uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/582337
[patent_app_country] => US
[patent_app_date] => 2000-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 44797
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562618.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582337 | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof | Sep 17, 2000 | Issued |
Array
(
[id] => 1290569
[patent_doc_number] => 06630304
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Human osteoporosis gene'
[patent_app_type] => B1
[patent_app_number] => 09/661887
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22872
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09661887
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/661887 | Human osteoporosis gene | Sep 13, 2000 | Issued |
Array
(
[id] => 1544798
[patent_doc_number] => 06444443
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Gene'
[patent_app_type] => B1
[patent_app_number] => 09/656952
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10694
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444443.pdf
[firstpage_image] =>[orig_patent_app_number] => 09656952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/656952 | Gene | Sep 6, 2000 | Issued |
| 09/581720 | METHOD FOR QUANTIFYING DENATURED LDL | Sep 5, 2000 | Abandoned |
Array
(
[id] => 1170670
[patent_doc_number] => 06753413
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'P35NCK5A binding proteins'
[patent_app_type] => B1
[patent_app_number] => 09/652603
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10043
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09652603
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/652603 | P35NCK5A binding proteins | Aug 29, 2000 | Issued |
Array
(
[id] => 1583915
[patent_doc_number] => 06358489
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Fluorination of proteins and peptides for F-18 positron emission tomography'
[patent_app_type] => B1
[patent_app_number] => 09/644706
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4303
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358489.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644706
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644706 | Fluorination of proteins and peptides for F-18 positron emission tomography | Aug 23, 2000 | Issued |
Array
(
[id] => 1533781
[patent_doc_number] => 06488937
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Allergy treatment method using a rapid immunotherapy protocol'
[patent_app_type] => B1
[patent_app_number] => 09/644719
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3830
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/488/06488937.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644719
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644719 | Allergy treatment method using a rapid immunotherapy protocol | Aug 22, 2000 | Issued |
| 09/530891 | Novel conjugates of rgd-containing peptides and endogenous carriers | Aug 15, 2000 | Abandoned |
Array
(
[id] => 1161995
[patent_doc_number] => 06759194
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders'
[patent_app_type] => B1
[patent_app_number] => 09/486167
[patent_app_country] => US
[patent_app_date] => 2000-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5795
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486167 | Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders | Aug 14, 2000 | Issued |
| 09/636179 | Angiogenesis targeting molecules | Aug 9, 2000 | Abandoned |
Array
(
[id] => 4345134
[patent_doc_number] => 06290958
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Anti-flea epoxide hydrolase antibodies and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/634530
[patent_app_country] => US
[patent_app_date] => 2000-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43924
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/290/06290958.pdf
[firstpage_image] =>[orig_patent_app_number] => 634530
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/634530 | Anti-flea epoxide hydrolase antibodies and uses thereof | Aug 7, 2000 | Issued |
| 09/555183 | SYNTHETIC PEPTIDES CONTAINING CITRULLINE RECOGNIZED BY RHEUMATOID ARTHRITIS SERA AS TOOLS FOR DIAGNOSIS AND TREATMENT | Aug 1, 2000 | Abandoned |
| 09/601274 | Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder | Jul 27, 2000 | Abandoned |
Array
(
[id] => 1280364
[patent_doc_number] => 06642013
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Extracellular serine protease'
[patent_app_type] => B1
[patent_app_number] => 09/618259
[patent_app_country] => US
[patent_app_date] => 2000-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 15576
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642013.pdf
[firstpage_image] =>[orig_patent_app_number] => 09618259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/618259 | Extracellular serine protease | Jul 17, 2000 | Issued |
| 09/529016 | METHOD FOR THE PURIFICATION OF IMMUNOGLOBULINS | Jul 16, 2000 | Abandoned |
Array
(
[id] => 459076
[patent_doc_number] => 07241443
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-10
[patent_title] => 'Immunogen adherence inhibitor and method of making and using same'
[patent_app_type] => utility
[patent_app_number] => 09/616843
[patent_app_country] => US
[patent_app_date] => 2000-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9058
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241443.pdf
[firstpage_image] =>[orig_patent_app_number] => 09616843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/616843 | Immunogen adherence inhibitor and method of making and using same | Jul 13, 2000 | Issued |
| 09/616865 | In vitro activated gamma delta lymphocytes | Jul 13, 2000 | Abandoned |
| 09/615437 | Bee venom treatment without the sting | Jul 12, 2000 | Abandoned |
| 60/327554 | Disease-associated gene | Jul 12, 2000 | Pending |
Array
(
[id] => 1531115
[patent_doc_number] => 06410020
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Monoclonal antibody reactive to human CETP and assay method for human CETP'
[patent_app_type] => B1
[patent_app_number] => 09/615404
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20437
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410020.pdf
[firstpage_image] =>[orig_patent_app_number] => 09615404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/615404 | Monoclonal antibody reactive to human CETP and assay method for human CETP | Jul 11, 2000 | Issued |
